BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 32649919)

  • 1. Circulating tumour cells as a potential biomarker for lung cancer screening: a prospective cohort study.
    Marquette CH; Boutros J; Benzaquen J; Ferreira M; Pastre J; Pison C; Padovani B; Bettayeb F; Fallet V; Guibert N; Basille D; Ilie M; Hofman V; Hofman P;
    Lancet Respir Med; 2020 Jul; 8(7):709-716. PubMed ID: 32649919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating tumour cells as a potential screening tool for lung cancer (the AIR study): protocol of a prospective multicentre cohort study in France.
    Leroy S; Benzaquen J; Mazzetta A; Marchand-Adam S; Padovani B; Israel-Biet D; Pison C; Chanez P; Cadranel J; Mazières J; Jounieaux V; Cohen C; Hofman V; Ilie M; Hofman P; Marquette CH;
    BMJ Open; 2017 Dec; 7(12):e018884. PubMed ID: 29282271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral arterial disease and systematic detection of circulating tumor cells: rationale and design of the DETECTOR prospective cohort study.
    Yannoutsos A; Fontaine M; Galloula A; Damotte D; Chatellier G; Paterlini-Bréchot P; Meyer G; Pastre J; Duchatelle V; Marini V; Schwering KL; Lazareth I; Ghaffari P; Stansal A; Sanson H; Labrousse C; Beaussier H; Nasr NB; Zins M; Salmeron S; Messas E; Lajonchère JP; Emmerich J; Priollet P; Trédaniel J
    BMC Cardiovasc Disord; 2019 Sep; 19(1):212. PubMed ID: 31519196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Participant selection for lung cancer screening by risk modelling (the Pan-Canadian Early Detection of Lung Cancer [PanCan] study): a single-arm, prospective study.
    Tammemagi MC; Schmidt H; Martel S; McWilliams A; Goffin JR; Johnston MR; Nicholas G; Tremblay A; Bhatia R; Liu G; Soghrati K; Yasufuku K; Hwang DM; Laberge F; Gingras M; Pasian S; Couture C; Mayo JR; Nasute Fauerbach PV; Atkar-Khattra S; Peacock SJ; Cressman S; Ionescu D; English JC; Finley RJ; Yee J; Puksa S; Stewart L; Tsai S; Haider E; Boylan C; Cutz JC; Manos D; Xu Z; Goss GD; Seely JM; Amjadi K; Sekhon HS; Burrowes P; MacEachern P; Urbanski S; Sin DD; Tan WC; Leighl NB; Shepherd FA; Evans WK; Tsao MS; Lam S;
    Lancet Oncol; 2017 Nov; 18(11):1523-1531. PubMed ID: 29055736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose CT screening among never-smokers with or without a family history of lung cancer in Taiwan: a prospective cohort study.
    Chang GC; Chiu CH; Yu CJ; Chang YC; Chang YH; Hsu KH; Wu YC; Chen CY; Hsu HH; Wu MT; Yang CT; Chong IW; Lin YC; Hsia TC; Lin MC; Su WC; Lin CB; Lee KY; Wei YF; Lan GY; Chan WP; Wang KL; Wu MH; Tsai HH; Chian CF; Lai RS; Shih JY; Wang CL; Hsu JS; Chen KC; Chen CK; Hsia JY; Peng CK; Tang EK; Hsu CL; Chou TY; Shen WC; Tsai YH; Tsai CM; Chen YM; Lee YC; Chen HY; Yu SL; Chen CJ; Wan YL; Hsiung CA; Yang PC;
    Lancet Respir Med; 2024 Feb; 12(2):141-152. PubMed ID: 38042167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of lung cancer through low-dose CT screening (NELSON): a prespecified analysis of screening test performance and interval cancers.
    Horeweg N; Scholten ET; de Jong PA; van der Aalst CM; Weenink C; Lammers JW; Nackaerts K; Vliegenthart R; ten Haaf K; Yousaf-Khan UA; Heuvelmans MA; Thunnissen E; Oudkerk M; Mali W; de Koning HJ
    Lancet Oncol; 2014 Nov; 15(12):1342-50. PubMed ID: 25282284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating tumor cell clusters are a potential biomarker for detection of non-small cell lung cancer.
    Manjunath Y; Upparahalli SV; Suvilesh KN; Avella DM; Kimchi ET; Staveley-O'Carroll KF; Li G; Kaifi JT
    Lung Cancer; 2019 Aug; 134():147-150. PubMed ID: 31319973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lung cancer incidence and mortality in National Lung Screening Trial participants who underwent low-dose CT prevalence screening: a retrospective cohort analysis of a randomised, multicentre, diagnostic screening trial.
    Patz EF; Greco E; Gatsonis C; Pinsky P; Kramer BS; Aberle DR
    Lancet Oncol; 2016 May; 17(5):590-9. PubMed ID: 27009070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison Between Radiological Semantic Features and Lung-RADS in Predicting Malignancy of Screen-Detected Lung Nodules in the National Lung Screening Trial.
    Li Q; Balagurunathan Y; Liu Y; Qi J; Schabath MB; Ye Z; Gillies RJ
    Clin Lung Cancer; 2018 Mar; 19(2):148-156.e3. PubMed ID: 29137847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating Tumor-Macrophage Fusion Cells and Circulating Tumor Cells Complement Non-Small-Cell Lung Cancer Screening in Patients With Suspicious Lung-RADS 4 Nodules.
    Manjunath Y; Suvilesh KN; Mitchem JB; Avella Patino DM; Kimchi ET; Staveley-O'Carroll KF; Pantel K; Yi H; Li G; Harris PK; Chaudhuri AA; Kaifi JT
    JCO Precis Oncol; 2022 Mar; 6():e2100378. PubMed ID: 35417204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "Sentinel" circulating tumor cells allow early diagnosis of lung cancer in patients with chronic obstructive pulmonary disease.
    Ilie M; Hofman V; Long-Mira E; Selva E; Vignaud JM; Padovani B; Mouroux J; Marquette CH; Hofman P
    PLoS One; 2014; 9(10):e111597. PubMed ID: 25360587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of direct referral for fast CT scan in early lung cancer detection in general practice. A clinical, cluster-randomised trial.
    Guldbrandt LM
    Dan Med J; 2015 Mar; 62(3):. PubMed ID: 25748876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of circulating tumor cells in patients with non-small cell lung cancer using epithelial marker-dependent and -independent approaches.
    Krebs MG; Hou JM; Sloane R; Lancashire L; Priest L; Nonaka D; Ward TH; Backen A; Clack G; Hughes A; Ranson M; Blackhall FH; Dive C
    J Thorac Oncol; 2012 Feb; 7(2):306-15. PubMed ID: 22173704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Occurrence and lung cancer probability of new solid nodules at incidence screening with low-dose CT: analysis of data from the randomised, controlled NELSON trial.
    Walter JE; Heuvelmans MA; de Jong PA; Vliegenthart R; van Ooijen PMA; Peters RB; Ten Haaf K; Yousaf-Khan U; van der Aalst CM; de Bock GH; Mali W; Groen HJM; de Koning HJ; Oudkerk M
    Lancet Oncol; 2016 Jul; 17(7):907-916. PubMed ID: 27283862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Lung Cancer Risk Among Persons Undergoing Screening or Guideline-Concordant Monitoring of Lung Nodules in the Mississippi Delta.
    Osarogiagbon RU; Liao W; Faris NR; Fehnel C; Goss J; Shepherd CJ; Qureshi T; Matthews AT; Smeltzer MP; Pinsky PF
    JAMA Netw Open; 2023 Feb; 6(2):e230787. PubMed ID: 36848089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lung cancer screening using low-dose computed tomography in at-risk individuals: the Toronto experience.
    Menezes RJ; Roberts HC; Paul NS; McGregor M; Chung TB; Patsios D; Weisbrod G; Herman S; Pereira A; McGregor A; Dong Z; Sitartchouk I; Boerner S; Tsao MS; Keshavjee S; Shepherd FA
    Lung Cancer; 2010 Feb; 67(2):177-83. PubMed ID: 19427055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance of lung cancer screening with low-dose CT in Gejiu, Yunnan: A population-based, screening cohort study.
    Wei MN; Su Z; Wang JN; Gonzalez Mendez MJ; Yu XY; Liang H; Zhou QH; Fan YG; Qiao YL
    Thorac Cancer; 2020 May; 11(5):1224-1232. PubMed ID: 32196998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Baseline results of the Depiscan study: a French randomized pilot trial of lung cancer screening comparing low dose CT scan (LDCT) and chest X-ray (CXR).
    Blanchon T; Bréchot JM; Grenier PA; Ferretti GR; Lemarié E; Milleron B; Chagué D; Laurent F; Martinet Y; Beigelman-Aubry C; Blanchon F; Revel MP; Friard S; Rémy-Jardin M; Vasile M; Santelmo N; Lecalier A; Lefébure P; Moro-Sibilot D; Breton JL; Carette MF; Brambilla C; Fournel F; Kieffer A; Frija G; Flahault A;
    Lung Cancer; 2007 Oct; 58(1):50-8. PubMed ID: 17624475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Smokers Health Multiple ACtions (SMAC-1) Trial: Study Design and Results of the Baseline Round.
    Antonicelli A; Muriana P; Favaro G; Mangiameli G; Lanza E; Profili M; Bianchi F; Fina E; Ferrante G; Ghislandi S; Pistillo D; Finocchiaro G; Condorelli G; Lembo R; Novellis P; Dieci E; De Santis S; Veronesi G
    Cancers (Basel); 2024 Jan; 16(2):. PubMed ID: 38254906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Results of the two incidence screenings in the National Lung Screening Trial.
    Aberle DR; DeMello S; Berg CD; Black WC; Brewer B; Church TR; Clingan KL; Duan F; Fagerstrom RM; Gareen IF; Gatsonis CA; Gierada DS; Jain A; Jones GC; Mahon I; Marcus PM; Rathmell JM; Sicks J;
    N Engl J Med; 2013 Sep; 369(10):920-31. PubMed ID: 24004119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.